Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1996-08-27
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548532, 548518, A61K 3140, C07D20722
Patent
active
055501486
ABSTRACT:
Compounds that selectively modulate the remodeling pathway of platelet activating factor (PAF) are described. Related pharmaceutical compositions and methods are also disclosed. These compounds, pharmaceutical compositions and methods are useful for reducing or eliminating inflammation.
REFERENCES:
Chao et al., Biochem. J. 292:617-629, 1993.
Sawa et al., J. Antibiotics 45(1):136-139, 1992.
Hayakawa et al., Tetrahedron Letters 32(2):213-216, 1991.
Henderson, J. Allergy Clin. Immunol. 79(4):543-553, 1987.
Venable et al., J. Lipid Res. 34:691-702, 1993.
Braquet et al., Pharmacological Reviews 39(2):97-145, 1987.
Ness Jeffrey Van
Varming Annemarie R.
West Robert R.
Leith Debra K.
Novo Nordisk A S
Parker Gary E.
Richter Johann
Sackey Ebenezer
LandOfFree
PAF synthesis modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PAF synthesis modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PAF synthesis modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1056436